Jeffrey S. Stonebraker, Ph.D.

Assistant Professor of Supply Chain Management

Department of Business Management

Poole College of Management

North Carolina State University

jsstoneb@ncsu.edu

Curriculum Vita pdf

Google Scholar Page http://scholar.google.com/citations?user=Lt5yJz4AAAAJ&hl=en


Education

Ph.D. Management Science, Arizona State University (December 1993). Dissertation: “Applying decision analysis to sequential decisions under uncertainty with continuous decision variables”

M.S. Engineering-Economic Systems, Stanford University (August 1988).

B.S. Electrical Engineering, University of South Florida (May 1983).

Research

Publications

  1. Stonebraker JS, Farrugia A, Gathmann B & ESID Registry Working Party, and Orange JS. Modeling Primary Immunodeficiency Disease Epidemiology and Its Treatment to Estimate Latent Therapeutic Demand for Immunoglobulin, Journal of Clinical Immunology 2014; 34(2): 233-244. pdf

  2. Stonebraker JS. Product-Generation Transition Decision Making for Bayer’s Hemophilia Drugs: Global Capacity Expansion under Uncertainty with Supply-Demand Imbalances. Operations Research 2013; 61(5): 1119-1133. pdf

  3. Stonebraker JS, Gill E, Kirkwood CW, and Handfield RB. Impact factor as a metric to assess journals where OM research is published. Journal of Operations Management 2012; 30(1): 24-43. pdf

  4. Stonebraker JS, Bolton-Maggs PHB, Soucie JM, Walker I, and Brooker M. A study of variations in the reported haemophilia B prevalence around the world. Haemophilia 2012; 18(3): e91-e94. pdf

  5. Handfield RB, Edwards SE, and Stonebraker JS. NC State’s Supply Chain Resource Cooperative educates in the real-world. Interfaces 2011; 41(6): 545-565. pdf

  6. Stonebraker JS, Bolton-Maggs PHB, Brooker M, Farrugia A, Srivastava A. A study of reported factor IX use around the world. Haemophilia 2011; 17(3): 446-455. pdf

  7. Stonebraker JS, Bolton-Maggs PHB, Soucie JM, Walker I, and Brooker M. A study of variations in the reported haemophilia A prevalence around the world. Haemophilia 2010; 16(1): 20-32. pdf

  8. Stonebraker JS, Brooker M, Amand RE, Farrugia A, and Srivastava A. A study of reported factor VIII use around the world. Haemophilia 2010; 16(1): 33-46. pdf

  9. Stonebraker JS and Keefer DL. Modeling potential demand for supply-constrained drugs: A new hemophilia drug at Bayer Biological Products. Operations Research 2009; 57(1): 19-31. pdf

  10. Stonebraker JS, Amand RE, Bauman MV, Nagle AJ, and Larson PJ. Modelling haemophilia epidemiology and treatment modalities to estimate unconstrained factor VIII demand. Haemophilia 2004; 10(1): 18-26. pdf

  11. Stonebraker JS, Amand RE, and Nagle AJ. A country-by-country comparison of FVIII concentrate consumption and economic capacity for the global haemophilia community. Haemophilia 2003; 9(3): 245-250. pdf

  12. Stonebraker JS. How Bayer makes decisions to develop new drugs. Interfaces 2002; 32(6): 77-90. pdf

  13. Dunning DJ, Lockfort S, Ross QE, Beccue PC, and Stonebraker JS. New York Power Authority uses decision analysis to schedule refueling of its Indian Point 3 Nuclear Power Plant. Interfaces 2001; 31(5): 121-135. pdf

  14. Stonebraker JS and Kirkwood CW. Formulating and solving sequential decision analysis models with continuous variables. IEEE Transactions on Engineering Management 1997; 44(1): 43-53. pdf

  15. Stonebraker JS, Farrugia A, and Gathmann B. A decision analysis model to estimate latent therapeutic demand for immunoglobulin therapy in primary immunodeficiencies. Proceedings of the 15th Meeting of the European Society of Immunodeficiencies 2013: 29-34. pdf

  16. Bailey MJ, Snapp J, Yetur S, Stonebraker JS, Edwards SA, Davis A, and Cox R. Practice Summaries: American Airlines uses should-cost modeling to assess the uncertainty of bids for its full-truckload shipment routes. Interfaces 2011; 41(2): 194-196. pdf

  17. Stonebraker JS, Sage JJ, and Leak BL. Practice Abstracts: Decision analysis provides insight to Ford Microelectronics Incorporated. Interfaces 1997; 27(2): 107-111, 1997. pdf

  18. Stonebraker JS and Keisler JM. Empirically investigating the portfolio management process: Findings from a large pharmaceutical company. In: Salo A, Keisler JM, and Morton A (Eds.) Portfolio Decision Analysis: Improved Methods for Resource Allocation, Springer, 201(Book won the 2013 INFORMS Decision Analysis Society Publication Award.)

  19. Beccue PC and Stonebraker JS. Balancing environmental and operational objectives in nuclear refueling strategies. In: Edwards W, Miles R, and von Winterfeldt D (Eds.) Advances in Decision Analysis, Cambridge UK: Cambridge University Press, 2007.

Working papers

Improving production capacity planning for immunoglobulin treatment of common variable immunodeficiency through probabilistic forecasting of the long-term global demand, planning to submit to Decision Analysis.

Research in Progress

Modeling hemophilia B epidemiology and treatment modalities to estimate latent therapeutic demand of factor IX.

Probabilistic forecasting of the global demand for the factor IX treatment of hemophilia B.

Production capacity under uncertainty.

Health-socioeconomic determinants of hemophilia A and B prevalence and factor VIII and IX use: A study of 114 countries.

Country-specific hemophilia demand models for the United States, Canada, and Australia.

Paper Presentations

Modeling Global FVIII and FIX Demand for the Treatment of Hemophilia A and B. World Federation of Hemophilia World Congress, Melbourne, Australia, 2014.

A framework for decision support analysis. The Supply Chain Resource Cooperative (28th Semi-Annual Partnership Meeting), Raleigh, NC, 2013.

Global Capacity Expansion under Uncertainty with Supply-Demand Imbalances. INFORMS national meeting, Minneapolis, MN, 2013.

Modeling latent therapeutic demand for common variable immunodeficiency. INFORMS national meeting, Phoenix, AZ, 2012.

A decision analysis model for estimating latent therapeutic demand for immunoglobulin therapy in primary immune deficiencies. 15th Biennial European Society for Immunodeficiencies meeting, Florence, Italy, 2012. (Presented by co-author)

Hemophilia Quality of Life. National Hemophilia Foundation meeting, Orlando, FL, 2012. (Panelist)

Modeling global FVIII and FIX demand for the treatment of hemophilia A and B – Country-specific demand models of latent therapeutic demand and economic development status. National Hemophilia Foundation meeting, Orlando, FL, 2012.

Demand Model for Primary Immune Deficiency. Plasma Proteins Therapeutics Association, Washington, DC, 2012.

Research in hemophilia A prevalence, factor VIII use, and latent therapeutic demand. University of North Carolina, School of Medicine, Chapel Hill, NC, 2011.

Exploratory study on a pharmaceutical company’s portfolio decision process. INFORMS national meeting, Charlotte, NC, 2011.

Using decision analysis to model the triune relationship of supply, demand, and price. INFORMS national meeting, Austin, TX, 2010.

Trends in FVIII use and Latent therapeutic demand – Where we’ve been and Where we’re going. Canadian Blood Services, Ottawa, Canada, 2010.

Using Impact Factor to evaluate and compare INFORMS journals. INFORMS national meeting, San Diego, CA, 2009.

Global factor usage and projected trends in supply and demand. The World Federation of Hemophilia Sixth Global Forum on the Safety and Supply of Treatment Products for Bleeding Disorders, Montreal, Canada, 2009.

Comments on building decision analysis approaches at the FDA. INFORMS national meeting, Washington, DC, 2008.

Medical Technology Evaluation & Assessment. INFORMS national meeting, Seattle, WA, 2007. (Session Chair for 2 sessions)

Understanding the supply-demand-price conundrum. The World Federation of Hemophilia Fifth Global Forum on the Safety and Supply of Treatment Products for Bleeding Disorders, Montreal, Canada, 2007.

The economics of the global market in treatment products for bleeding disorders. The World Federation of Hemophilia Fifth Global Forum on the Safety and Supply of Treatment Products for Bleeding Disorders, Montreal, Canada, 2007. (Panelist)

Analyzing a portfolio decision process. INFORMS national meeting, Pittsburgh, PA, 2006.

Best of INFORMS—Modeling the global latent therapeutic demand for hemophilia A. Decision Analysis Affinity Group conference, Philadelphia, PA, 2005.

Modeling the global latent therapeutic demand for hemophilia A. INFORMS national meeting, Denver, CO, 2004.

De-coupling supply from demand to make an informed business decision. INFORMS national meeting, Atlanta, GA, 2003.

What makes for a successful decision analysis? INFORMS national meeting, Atlanta, GA, 2003. (Panelist)

Therapeutic factor VIII demand model. International Hemophilia Advisory Board meeting, Rome, Italy, 2003.

Commercial evaluation of a blood clot-busting drug. INFORMS national meeting, San Jose, CA, 2002.

Using decision analysis to right-size a manufacturing facility. Decision Analysis Affinity Group conference, Las Vegas, NV, 2002.

Are you ready for the MODA of all portfolio prioritization approaches or is SODA still appropriate. Decision Analysis Affinity Group conference, Houston, TX, 2001.

Using decision analysis to find the right portfolio balance. Pharmaceutical Portfolio Management conference, Philadelphia, PA, 2000.

Learning to learn. INFORMS national meeting, San Diego, CA, 1997.

How do we prepare students to become effective decision makers and/or analysts?. INFORMS national meeting, San Diego, CA, 1997.

Quality Air Force at Air Mobility Command. INFORMS national meeting, Atlanta, GA, 1996.

Tutorial on value-focused thinking. MORS symposium, Fort Leavenworth, KS, 1996.

Multiobjective decision analysis applied to the Air Force’s Base Closure and Realignment Selection Process. INFORMS national meeting, Washington, DC, 1996. (Presented by co-author)

Decision analysis efforts at the U.S. Air Force Academy. INFORMS national meeting, Washington, DC, 1996. (Session Chair)

Teaching the practice of decision analysis. INFORMS national meeting, New Orleans, LA, 1995.

Tutorial on the practicality of decision analysis. MORS symposium, United States Naval Academy, MD, 1995.

Principles and practice of decision analysis. INFORMS national meeting, Los Angeles, CA, 1995. (Session Chair)

Formulating sequential decisions under uncertainty having continuous variables. TIMS/ORSA national meeting, Boston, MA, 1994.

Applying decision analysis to sequential decisions under uncertainty with continuous decision variables. ORSA/TIMS national meeting, Phoenix, AZ, 1993.

Decision analysis as a TQM tool: An application to the Baldrige Quality Award. ORSA/TIMS national meeting, Phoenix, AZ, 1993. (Presented by co-author)

Applying decision analysis to source selection. MORS symposium, United States Military Academy, NY, 1991.

Decision analysis at the United States Air Force Academy. TIMS/ORSA national meeting, Nashville, TN, 1991.

Rational decision making and source selection for defense systems. TIMS/ORSA national meeting, Nashville, TN, 1991. (Presented by co-author)

Decision theory in source selection for defense systems acquisition. TIMS/ORSA national meeting, Las Vegas, NV, 1990. (Presented by co-author)

Teaching

My teaching is in the area of operations. I have taught:

Grants and Awards